GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Geron Corp (STU:GON) » Definitions » Purchase Of Investment

Geron (STU:GON) Purchase Of Investment : €-445.44 Mil (TTM As of Dec. 2024)


View and export this data going back to 1996. Start your Free Trial

What is Geron Purchase Of Investment?

Geron's purchase of investment for the three months ended in Dec. 2024 was €-176.48 Mil. It means Geron spent €176.48 Mil on purchasing investments. Geron's purchase of investment for the trailing twelve months (TTM) ended in Dec. 2024 was €-445.44 Mil.

Compared with last quarter (€-59.29 Mil in Sep. 2024 ), Geron spent more money on purchasing investments in Dec. 2024 (€-176.48 Mil).

Geron Purchase Of Investment Historical Data

The historical data trend for Geron's Purchase Of Investment can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Geron Purchase Of Investment Chart

Geron Annual Data
Trend Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23 Dec24
Purchase Of Investment
Get a 7-Day Free Trial Premium Member Only Premium Member Only -257.45 -157.03 -243.56 -436.12 -455.47

Geron Quarterly Data
Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24
Purchase Of Investment Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -14.55 -60.37 -149.30 -59.29 -176.48

Geron Purchase Of Investment Calculation

Purchase of Investments represents cash outflow on the purchase of investments in securities.

Purchase Of Investment for the trailing twelve months (TTM) ended in Dec. 2024 adds up the quarterly data reported by the company within the most recent 12 months, which was €-445.44 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Geron Purchase Of Investment Related Terms

Thank you for viewing the detailed overview of Geron's Purchase Of Investment provided by GuruFocus.com. Please click on the following links to see related term pages.

Geron Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Geron Corp (STU:GON) » Definitions » Purchase Of Investment
Comparable Companies
ELVN PHVS NRIX RCUS ZYME MLYS NTLA SYRE GYRE VIR VRTX ASX:CSL REGN XKRX:207940 XBRU:ARGX ALNY XBRU:UCB ONC BNTX XKRX:068270
Traded in Other Exchanges
GERN:USA 0IV3:UK
Address
919 East Hillsdale Boulevard, Suite 250, Foster City, CA, USA, 94404
Website
https://www.geron.com
Geron Corp is a clinical-stage biopharmaceutical company focused on the research and development of cancer treatments. The company's drug in development, Imelstat, is being tested for the treatment of myelodysplastic syndromes, which are disorders of the blood, and myelofibrosis, which is a rare blood cancer affecting bone marrow. The company earns revenue through collaboration agreements, milestones, royalties, and licensing arrangements. Geron possesses various rights to this drug. The company operates as a single segment being, the development of therapeutic products for oncology.

Geron Headlines

No Headlines